Memory B cells from a subset of treatment-naïve relapsing-remitting multiple sclerosis patients elicit CD4+ T-cell proliferation and IFN-γ production in response to myelin basic protein and myelin oligodendrocyte glycoprotein-Reference-Cited by-同舟云学术

Memory B cells from a subset of treatment-naïve relapsing-remitting multiple sclerosis patients elicit CD4+ T-cell proliferation and IFN-γ production in response to myelin basic protein and myelin oligodendrocyte glycoprotein

Published:2010-08-02 Issue:10 Volume:40 Page:2942-2956
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur. J. Immunol.

Author:

Harp Christopher T.,Ireland Sara,Davis Laurie S.,Remington Gina,Cassidy Bonnie,Cravens Petra D.,Stuve Olaf,Lovett-Racke Amy E.,Eagar Todd N.,Greenberg Benjamin M.,Racke Michael K.,Cowell Lindsay G.,Karandikar Nitin J.,Frohman Elliot M.,Monson Nancy L.

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Reference70 articles.

1. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis;Hauser;N. Engl. J. Med.,2008

2. Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?;Bar-Or;Ann. Neurol,2010

3. Long-term B-lymphocyte depletion with rituximab in patients with relapsing-remitting multiple sclerosis;Stuve;Arch. Neurol.,2009

4. Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis;Krumbholz;Neurology,2008

5. Innate responses of B cells;Gray;Eur. J. Immunol.,2007

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HLA-transgenic mouse models to study autoimmune central nervous system diseases;Autoimmunity;2024-08-21

2. Intruders or protectors – the multifaceted role of B cells in CNS disorders;Frontiers in Cellular Neuroscience;2024-01-10

3. Neurodegeneration in autoimmune central nervous system infection;A Review on Diverse Neurological Disorders;2024

4. A Dual Role of Osteopontin in Modifying B Cell Responses;Biomedicines;2023-07-12

5. A dual role of osteopontin in modifying B cell responses;2023-02-16